Compare Divis Laboratories with Dr. Reddys - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs DR. REDDYS LAB - Comparison Results

DIVIS LABORATORIES     Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

DR. REDDYS LAB 
   Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the pharmaceutical value chain - basic research, finished dosages, generics, bulk actives, and biotechnology. The company's business is mainly organized into Global g... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DIVIS LABORATORIES DR. REDDYS LAB DIVIS LABORATORIES/
DR. REDDYS LAB
 
P/E (TTM) x 60.3 54.1 111.5% View Chart
P/BV x 13.9 5.4 256.0% View Chart
Dividend Yield % 0.4 0.5 89.9%  

Financials

 DIVIS LABORATORIES   DR. REDDYS LAB
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-19
DR. REDDYS LAB
Mar-20
DIVIS LABORATORIES/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs1,6393,363 48.7%   
Low Rs1,1152,352 47.4%   
Sales per share (Unadj.) Rs186.31,054.2 17.7%  
Earnings per share (Unadj.) Rs51.0121.9 41.8%  
Cash flow per share (Unadj.) Rs57.3190.2 30.1%  
Dividends per share (Unadj.) Rs16.0025.00 64.0%  
Dividend yield (eoy) %1.20.9 132.8%  
Book value per share (Unadj.) Rs261.8938.7 27.9%  
Shares outstanding (eoy) m265.47166.17 159.8%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x7.42.7 272.7%   
Avg P/E ratio x27.023.4 115.3%  
P/CF ratio (eoy) x24.015.0 159.9%  
Price / Book Value ratio x5.33.0 172.8%  
Dividend payout %31.420.5 153.1%   
Avg Mkt Cap Rs m365,592474,831 77.0%   
No. of employees `00011.821.7 54.7%   
Total wages/salary Rs m5,42333,802 16.0%   
Avg. sales/employee Rs Th4,175.18,091.0 51.6%   
Avg. wages/employee Rs Th457.71,561.3 29.3%   
Avg. net profit/employee Rs Th1,141.8935.8 122.0%   
INCOME DATA
Net Sales Rs m49,463175,170 28.2%  
Other income Rs m1,5566,206 25.1%   
Total revenues Rs m51,019181,376 28.1%   
Gross profit Rs m18,71824,421 76.6%  
Depreciation Rs m1,68911,348 14.9%   
Interest Rs m35983 3.6%   
Profit before tax Rs m18,55118,296 101.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m0561 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,023-1,403 -358.0%   
Profit after tax Rs m13,52720,260 66.8%  
Gross profit margin %37.813.9 271.4%  
Effective tax rate %27.1-7.7 -353.1%   
Net profit margin %27.311.6 236.5%  
BALANCE SHEET DATA
Current assets Rs m46,501125,991 36.9%   
Current liabilities Rs m8,46872,141 11.7%   
Net working cap to sales %76.930.7 250.1%  
Current ratio x5.51.7 314.4%  
Inventory Days Days13173 179.0%  
Debtors Days Days86105 81.9%  
Net fixed assets Rs m25,79783,854 30.8%   
Share capital Rs m531831 63.9%   
"Free" reserves Rs m68,962155,157 44.4%   
Net worth Rs m69,493155,988 44.6%   
Long term debt Rs m01,304 0.0%   
Total assets Rs m80,383232,253 34.6%  
Interest coverage x531.019.6 2,707.6%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.60.8 81.6%   
Return on assets %16.99.1 184.5%  
Return on equity %19.513.0 149.9%  
Return on capital %26.712.6 212.0%  
Exports to sales %00-   
Imports to sales %24.60-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m12,187NA-   
Fx inflow Rs m41,23884,193 49.0%   
Fx outflow Rs m12,40539,616 31.3%   
Net fx Rs m28,83344,577 64.7%   
CASH FLOW
From Operations Rs m9,54329,841 32.0%  
From Investments Rs m-6,854-4,923 139.2%  
From Financial Activity Rs m-2,459-25,159 9.8%  
Net Cashflow Rs m230-266 -86.3%  

Share Holding

Indian Promoters % 52.0 25.5 203.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 11.8 5.4 218.5%  
FIIs % 19.0 35.3 53.8%  
ADR/GDR % 0.0 18.5 -  
Free float % 17.2 15.3 112.4%  
Shareholders   31,796 75,885 41.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DIVIS LABORATORIES With:   FDC  UNICHEM LAB  PROCTER & GAMBLE HEALTH  AJANTA PHARMA  ALEMBIC  

Compare DIVIS LABORATORIES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Higher; Metal and IT Stocks Lead(09:30 am)

Asian share markets are trading on a mixed note today. The Nikkei is trading lower by 0.5% and the Hang Seng is trading up by 0.2%.

Related Views on News

DIVIS LABORATORIES Announces Quarterly Results (1QFY21); Net Profit Up 84.1% (Quarterly Result Update)

Aug 10, 2020 | Updated on Aug 10, 2020

For the quarter ended June 2020, DIVIS LABORATORIES has posted a net profit of Rs 5 bn (up 84.1% YoY). Sales on the other hand came in at Rs 17 bn (up 50.0% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (4QFY20); Net Profit Up 35.4% (Quarterly Result Update)

Jun 8, 2020 | Updated on Jun 8, 2020

For the quarter ended March 2020, DIVIS LABORATORIES has posted a net profit of Rs 4 bn (up 35.4% YoY). Sales on the other hand came in at Rs 14 bn (up 9.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (3QFY20); Net Profit Down 4.9% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, DIVIS LABORATORIES has posted a net profit of Rs 4 bn (down 4.9% YoY). Sales on the other hand came in at Rs 14 bn (up 3.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (2QFY20); Net Profit Down 10.3% (Quarterly Result Update)

Nov 11, 2019 | Updated on Nov 11, 2019

For the quarter ended September 2019, DIVIS LABORATORIES has posted a net profit of Rs 4 bn (down 10.3% YoY). Sales on the other hand came in at Rs 14 bn (up 12.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES 2018-19 Annual Report Analysis (Annual Result Update)

Oct 10, 2019 | Updated on Oct 10, 2019

Here's an analysis of the annual report of DIVIS LABORATORIES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.

More Views on News

Most Popular

'Essential' Smallcap Stock Recommendations(Profit Hunter)

Jan 8, 2021

The smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.

Is Nifty Forming a Top(Fast Profits Daily)

Jan 8, 2021

The charts are telling the bulls to be cautious.

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

A Rare Chance to Invest in Potential Multibaggers in 2021(Profit Hunter)

Jan 11, 2021

Our ace stock picker is ready to capitalise on a big growth opportunity.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

DIVIS LABORATORIES SHARE PRICE


Jan 20, 2021 09:38 AM

TRACK DIVIS LABORATORIES

  • Track your investment in DIVIS LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DIVIS LABORATORIES

DIVIS LABORATORIES - IPCA LABS COMPARISON

COMPARE DIVIS LABORATORIES WITH

MARKET STATS